IBA

World leader in particle accelerator technology and key player in the fight against cancer IBA (Ion Beam Applications S.A.)

is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approxi

mately 1,600 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.

21/05/2026

📢 Press release

IBA today announces its business update for the first quarter of 2026, starting the year on track with product innovation progress.

Olivier Legrain, Chief Executive Officer of IBA, commented: “We are pleased with our start to 2026, with a stable backlog and solid financial position. Commercial activity was mostly led by RadioPharma Solutions, and Proton Therapy continued to progress with an active pipeline and additional clinical evidence supporting reimbursement. We also delivered important innovation milestones across the Group, while PanTera reached key regulatory steps to support clinical partners in targeted alpha therapy.”

🔗 Read the full press release here: https://www.iba-worldwide.com/first-quarter-2026-update-starting-year-track-product-innovation-progress

20/05/2026

📢 Press release

IBA Industrial Solutions launches Rhodotron® LITE, a new low‑power X‑ray accelerator expanding access to sustainable irradiation solutions.

🔗 Read the full press release here: https://www.iba-worldwide.com/iba-launches-rhodotronr-lite-new-low-power-x-ray-accelerator-expanding-access-sustainable

13/05/2026

📢 Press release

IBA Proton Therapy introduces AdaPTinsight XR, the next generation of CBCT imaging for image-guided proton therapy.

🔗 Read the full press release here: https://www.iba-worldwide.com/iba-introduces-adaptinsight-xr-next-generation-cbct-imaging-image-guided-proton-therapy

05/05/2026

🎉 40 years of IBA

Last week, IBA marked a major milestone: 40 years of innovation in particle accelerator technology, celebrated with colleagues and external partners.

From a pioneering vision to a global leader, IBA’s journey has been shaped by people and shared values. Celebrating this moment with our customers, suppliers, partners and colleagues, around the values that define IBA - Care, Share, Dare and Be Fair - made it even more meaningful.

Thank you for being part of the IBA story, past, present and future. 🚀

29/04/2026

🌍 What if your next career step was also an international adventure?

Discover how our colleagues live worldwide careers at IBA, growing professionally, embracing new cultures, and building lasting memories.

👉 Ready for your own experience? Visit IBA Career site: https://careers.iba-worldwide.com/

28/04/2026

Viggo was IBA’s very special guest at our 40th birthday celebration. His story reminds us every day why we do what we do. 💚

24/04/2026

📢 Press release

The top 250 worldwide cancer specialists converge in Belgium to push the frontiers of proton therapy.

IBA Proton Therapy starts today its Proteus User Meeting 2026. Oncologists, physicists, clinicians from the most prestigious cancer care institutions across the Americas, Europe and Asia-Pacific will gather for the largest meeting of proton therapy experts.

🔗 Read the full press release here: https://www.iba-worldwide.com/top-250-cancer-specialists-converge-belgium-push-frontiers-proton-therapy

22/04/2026

Yesterday, we were honored to welcome His Majesty King Philippe of Belgium to IBA as part of the interregional royal economic visit. 🇧🇪👑

As a university spin‑off, IBA demonstrates how the expertise and dedication of our colleagues turn academic research excellence into a world‑class technology champion, serving a deeply human mission in the fight against cancer. 🔬

07/04/2026

🔬On this World Health Day - “Together for Health. Stand with Science.”, IBA reaffirms the essential role of science in advancing global health.

Every day, our technologies help support diagnosis, treatment, and patient safety worldwide.

Together, we can drive progress and shape a healthier future for all. 🌍

27/03/2026

📢 Press release

IBA delivers strong full-year results for 2025 with solid ex*****on in all segments.

Olivier Legrain, Chief Executive Officer of IBA, commented: "2025 marked a year of strong ex*****on for IBA, with a record revenue and improved profitability, enabling us to deliver on our guidance. Momentum across our core businesses is robust, supported by progress in Proton Therapy and growing engagement in nuclear medicine. With a strengthened financial structure and increased visibility on future activity, we are well positioned to continue executing our strategy with confidence."

🔗 Read the full press release here: https://www.iba-worldwide.com/iba-delivers-strong-fy-2025-results-solid-ex*****on-all-segments

25/03/2026

🌟 Inspiring the next generation of STEM talent

At IBA, we welcome students throughout the year to explore STEM (Science, Technology, Engineering and Mathematics) careers and meet the people behind our technologies. 🔬

Since September, more than 300 students, from universities, secondary schools, and teacher‑training programs, have visited our Louvain‑la‑Neuve site.

🌍 These initiatives reflect IBA’s societal mission, especially at a time when Europe faces a growing need for STEM professionals. Programs like Innovat’her, a dedicated event for secondary‑school girls, also help encourage more young women to pursue these fields.

Thank you to all the students for their curiosity, and to our colleagues for making these visits truly inspiring. 🙏

Adres

Louvain-la-Neuve

Website

http://www.iba-worldwide.com/

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer IBA nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.